All

Undercounting– Again

by C. Scott McMillin | Nov 12, 2020 | In the News | 0 |

And like the opioid epidemic, the virus disproportionately harmed the disadvantaged and minorities among us.

Medicaid Expands – Finally

by C. Scott McMillin | Aug 27, 2020 | In the News, Public Health | 2 |
Undercounted

by C. Scott McMillin | Mar 19, 2020 | Public Health | 0 |
Old Diseases Made New

by C. Scott McMillin | Mar 16, 2020 | Prevention, Public Policy | 0 |
Fentanyl Goes West

by C. Scott McMillin | Sep 30, 2019 | Addictive Substances, Public Health | 0 |
Vaping Disease

by C. Scott McMillin | Sep 9, 2019 | In the News, Public Health | 0 |

Word of Warning

by C. Scott McMillin | Jul 1, 2019 | Public Health | 0 |

Cannabis doesn’t replace opioids the way methadone or buprenorphine do. There’s no antagonist effect as with naloxone or naltrexone.

Stimulants Today

by C. Scott McMillin | Jun 17, 2019 | Addictive Substances, Public Health | 0 |

The list of deaths from the practice is long and oddly prestigious, featuring celebs such as John Belushi and Chris Farley, among many others.

Big City Opioids

by C. Scott McMillin | Jan 17, 2019 | Public Health | 0 |

Now, with the introduction of fentanyl and carfentanil, the decision to inject heroin or cocaine can easily result in a fatality.

Synergism Strikes

by C. Scott McMillin | Jan 3, 2019 | Addictive Substances, Public Health | 0 |

Then there are the users who seek to overcome their own elevated tolerance, which interferes with ordinary drug-taking, by simultaneously consuming a second substance of the same general effect

Dark Fentanyl

by C. Scott McMillin | Dec 27, 2018 | Thinking About Addiction | 0 |

Drug dealers at the higher levels of the marketplace are much like other businesspeople in their natural aversion to bad publicity.

Dayton Gets Results

by C. Scott McMillin | Dec 17, 2018 | Prevention, Public Policy | 1 |

We should remember that Ohio’s Republican governor had to go against the wishes of many in his own party in order to achieve this.

In the News: Polypharmacy and Tom Petty

by C. Scott McMillin | Feb 12, 2018 | In the News | 2 |

It’s the result of a problem in medicine that’s been going on since before I ever started working in the field. The drugs have changed, but the results haven’t.